Evidence check: ApoB in the context of Abnehmen

ApoB (Apolipoprotein B) is a well-established risk marker for cardiovascular disease, not directly for weight loss. Studies show that weight loss—especially through calorie restriction—can lower ApoB levels, but the effect is usually modest and highly dependent on individual metabolism. ApoB reflects the number of atherogenic lipoproteins (mainly LDL) and is considered a more precise predictor of cardiovascular events than LDL cholesterol alone. In the context of weight loss, a high ApoB value may indicate elevated risk that can be improved through weight reduction and lifestyle changes. However, ApoB is not a direct marker of fat burning or diet success. The evidence linking ApoB to cardiovascular outcomes is strong (human-strong), but its specific role in weight loss is indirect. Consumer tests measuring ApoB can provide a clue but should not be the sole basis for dietary decisions. Caveat: single measurements are error-prone; medical interpretation and a full lipid panel are advisable.